Cargando…

Circulating DNA and Micro-RNA in Patients with Pancreatic Cancer

Collecting repeat samples of blood (“liquid biopsies”) is a broadly used clinical approach for serial monitoring of disease or response to treatments. In patients with cancer the most distinct molecular feature are somatic mutations acquired by cancer cells present in the diseased tissue. Indeed, mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vietsch, Eveline E, van Eijck, Casper HJ, Wellstein, Anton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494744/ https://www.ncbi.nlm.nih.gov/pubmed/26161297 http://dx.doi.org/10.4172/2165-7092.1000156

Ejemplares similares

Distinct Response of Circulating microRNAs to the Treatment of Pancreatic Cancer Xenografts with FGFR and ALK Kinase Inhibitors
por: Peran, Ivana, et al.
Publicado: (2022)

Circulating biomarkers to monitor cancer progression and treatment
por: Rapisuwon, Suthee, et al.
Publicado: (2016)

Circulating microRNAs in patients with hormone receptor-positive, metastatic breast cancer treated with dovitinib
por: Shivapurkar, Narayan, et al.
Publicado: (2017)

Immune-Related Circulating miR-125b-5p and miR-99a-5p Reveal a High Recurrence Risk Group of Pancreatic Cancer Patients after Tumor Resection
por: Vietsch, Eveline E., et al.
Publicado: (2019)

Circulating Biomarkers for Prediction of Objective Response to Chemotherapy in Pancreatic Cancer Patients
por: van der Sijde, Fleur, et al.
Publicado: (2019)

Cardiomyocyte-specific circulating cell-free methylated DNA in esophageal cancer patients treated with chemoradiation
por: Roth, Sarah Martinez, et al.
Publicado: (2021)

Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma
por: Farshadi, Elham Aida, et al.
Publicado: (2021)

Impaired CXCL12 signaling contributes to resistance of pancreatic cancer subpopulations to T cell-mediated cytotoxicity
por: Lin, Yuan-Na, et al.
Publicado: (2022)

Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer
por: TIAN, XUEFEI, et al.
Publicado: (2016)

Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX
por: van der Sijde, Fleur, et al.
Publicado: (2021)

Recurrence of Early Stage Colon Cancer Predicted by Expression Pattern of Circulating microRNAs
por: Shivapurkar, Narayan, et al.
Publicado: (2014)

B cell immune profiles in dysbiotic vermiform appendixes of pancreatic cancer patients
por: Vietsch, Eveline E., et al.
Publicado: (2023)

Detection of Cell Types Contributing to Cancer From Circulating, Cell-Free Methylated DNA
por: Barefoot, Megan E., et al.
Publicado: (2021)

Correction: Recurrence of Early Stage Colon Cancer Predicted by Expression Pattern of Circulating microRNAs
por: Shivapurkar, Narayan, et al.
Publicado: (2014)

Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients
por: van der Sijde, Fleur, et al.
Publicado: (2022)

Robust deep learning model for prognostic stratification of pancreatic ductal adenocarcinoma patients
por: Ju, Jie, et al.
Publicado: (2021)

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
por: Janssen, Quisette P., et al.
Publicado: (2020)

Tissue and Serum microRNAs in the Kras(G12D) Transgenic Animal Model and in Patients with Pancreatic Cancer
por: LaConti, Joseph J., et al.
Publicado: (2011)

Clinical Trials Targeting the Stroma in Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: van Mackelenbergh, Madelaine G., et al.
Publicado: (2019)

Pancreatic Duct Obstruction in a Middle-Aged Woman: A Case Report
por: Suker, Mustafa, et al.
Publicado: (2017)

Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer
por: Wang, Jin, et al.
Publicado: (2014)

Quality of life of locally advanced pancreatic cancer patients after FOLFIRINOX treatment
por: van der Sijde, Fleur, et al.
Publicado: (2021)

Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients
por: de Koning, Willem, et al.
Publicado: (2023)

Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study
por: van der Sijde, Fleur, et al.
Publicado: (2021)

FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study
por: Suker, Mustafa, et al.
Publicado: (2018)

Salivary MicroRNA in Pancreatic Cancer Patients
por: Humeau, Marine, et al.
Publicado: (2015)

Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer
por: Blaauboer, Amber, et al.
Publicado: (2020)

The yield of chest computed tomography in patients with locally advanced pancreatic cancer
por: Suker, Mustafa, et al.
Publicado: (2020)

Evaluation of Circulating MicroRNA Biomarkers in the Acute Pancreatic Injury Dog Model
por: Lee, Han-Byul, et al.
Publicado: (2018)

Clinically relevant circulating microRNA profiling studies in pancreatic cancer using meta-analysis
por: Pei, Zenglin, et al.
Publicado: (2017)

ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancers
por: Wellstein, Anton
Publicado: (2012)

Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells
por: Booy, Stephanie, et al.
Publicado: (2014)

Comparison between intratumoral and intravenously administered oncolytic virus therapy with Newcastle disease virus in a xenograft murine model for pancreatic adenocarcinoma
por: de Graaf, J. Fréderique, et al.
Publicado: (2022)

The Daily Practice of Pancreatic Enzyme Replacement Therapy After Pancreatic Surgery: a Northern European Survey: Enzyme Replacement After Surgery
por: Sikkens, Edmée C. M., et al.
Publicado: (2012)

Increasing Systemic Immune-inflammation Index During Treatment in Patients With Advanced Pancreatic Cancer is Associated With Poor Survival: A Retrospective, Multicenter, Cohort Study
por: van ‘t Land, Freek R., et al.
Publicado: (2023)

MicroRNA-125a-3p, -4530, and -92a as a Potential Circulating MicroRNA Panel for Noninvasive Pancreatic Cancer Diagnosis
por: Seyed Salehi, Ali, et al.
Publicado: (2022)

Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma
por: Buijs, Pascal, et al.
Publicado: (2015)

A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer
por: Lai, Xianyin, et al.
Publicado: (2017)

The Role of microRNA in Pancreatic Cancer
por: Smolarz, Beata, et al.
Publicado: (2021)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
por: Polasik, Arkadius, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1nofg1lmvf7vjoueqi5s6ffihm